Abstract: A method for handing off diagnostic test results to a telemedicine provider is provided. The method comprises receiving diagnostic test results in response to a diagnostic test, determining if the diagnostic test results include a positive result, storing the diagnostic test results on a server disposed on a network, sending the diagnostic test results from the server to the telemedicine provider, sending additional medical history information to the telemedicine provider, and initiating a telemedicine conference with the telemedicine provider.

Abstract: A microfluidic chip device includes a reservoir for holding a biologic sample containing a predetermined biologic material. A first plurality of parallel pathways each testing one of one or more treatment-agents and analyzing a first efficacy for each of the one or more treatment agents applied to the predetermined biologic material within the biologic sample. A multiplexer provides a portion of the biologic sample into each of the first plurality of parallel pathways from the reservoir. A second plurality of parallel pathways each test a plurality of different dosage levels of the one or more treatment agents and analyzes a second efficacy of the plurality of different dosage levels with respect to the predetermined biologic material. The multiplexer further provides a second portion of the biologic sample into a selected at least one of the second plurality of parallel pathways responsive to a control input indicating the treatment agent providing a highest efficacy.

Abstract: A system for image capture and analysis that includes a database storing a plurality of first, second and third medical codes. The first medical codes are associated with diagnostic test identifiers, the second medical codes are associated with a test result and the third medical codes are associated with a recommended pharmaceutical product. A server is disposed on a network that includes a program therein for configuring the server to receive from a mobile device an image of a retail testing product. The server detects a diagnostic test identifier of the retail testing product in the image. The diagnostic test identifier identifies a type of test performed by the retail testing product. The server retrieves a first medical code from a database associated with the diagnostic test identifier and the retail testing product. The server performs digital image processing on the image of the retail testing product and determines test results indicated by the digitally processed image of the retail testing product.

Abstract: A system for creating a unique transaction ID (UTID) securely representing a medical diagnostic transaction between a user/patient and a telemedicine professional is provided. The system includes a first central office database configured to store medical information and profile information for a plurality of users/patients, a second central office database configured to store UTIDs, a memory, and a processor coupled to the memory. The processor is configured to receive test information, initiate generation of a UTID for the new diagnostic transaction, analyze the received test information to determine if the test information indicates a positive or a negative result, transfer the analysis results back to the user/patient's MU, and receive from the MU a request for a telemedicine professional session.

Abstract: A method for initiating a telemedicine conference on a mobile device that receives at least one image of a diagnostic testing device having a test result area at a server. Digital image processing is performed on the at least one image of the diagnostic testing device. The processing recognizes, in the at least one image, a diagnostic test identifier on the diagnostic testing device. The diagnostic test identifier identifies that the diagnostic testing device that is associated with testing of a specific medical condition. Colored pixels are counted in at least a portion of the test result area in the at least one image. A color intensity of digital pixels in the counted colored pixels is identified in the test result area of the at least one image. Diagnostic test results are determined based on the identified color intensity of the digital pixels in the test result area in the at least one image.

Abstract: A system for providing colorimetric and ratiometric comparison and quantification for medical test results, comprising a testing device including an alignment target and including a plurality of immunoassay test strips, the plurality of immunoassay test strips each including a test line and a control line, and a colorimetry device configured to operate with a mobile device, the mobile device including a camera and a software application stored thereon, wherein the software application provides executable instructions to detect color properties of a color of the test line and a color of a control line of at least one of the plurality of immunoassay test strips, determine a risk value for each of at least one disease risks tested using the biologic sample, wherein the risk value is a rating determined from the color properties of the color of the test line, and provide medical test results based on the risk value.

Abstract: A microfluidic chip system includes an input for receiving the biologic sample, and a first reading window for enabling a detection of the biologic material within the biologic sample. A first plurality of pathways is provided each for determining a treatment agent providing a best treatment efficacy for the predetermined biologic material. A first micro-pump is provided for pumping a portion of the biologic sample into each of the first plurality of pathways. A second plurality of pathways is provided, each for determining a dosage level of a particular one of the plurality of treatment agents with respect to the predetermined biologic material. A plurality of second micro-pumps are provided for pumping a second portion of the biologic sample into a selected one of the second plurality of pathways responsive to the determination of treatment efficacy of the treatment agent providing a best treatment of the predetermined biologic material.

Abstract: A system and method are provided for presenting self-diagnostic test instructions in the form of audiovisual messages. The system and method include collecting by a user of a testing device a biologic sample for use with a testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects of the system and method present test instructions to the user in the form of audiovisual messages. The audiovisual messages are provided to the user as a response to an interaction with a retail diagnostic product. In some aspects, the complete audiovisual message is presented before the user may complete a self-diagnostic test.

Abstract: A two-sided flow-through immunoassay testing device is provided. The device comprises a well having therein a plurality of orifices, the plurality of orifices serving to channel biologic material deposited into the well onto different immunoassay pods, wherein the immunoassay pods may contain immunoassay test layers stacked to create an immunoassay test. The device further includes a results window. Inside the device, and between the window and the pods, there are open sections below each pod to allow a user to view the results of the tests as presented on the reaction layers of the pods through the window.

Abstract: A method for providing immunoassay test results includes collecting at least one biologic with a testing device, conjugating the biologic with particles on a conjugate pad of a test strip to create an immune complex, binding antigens or antibodies of the immune complex to antigens or antibodies of a test line, providing a software application to be stored on a mobile device having a camera; capturing an image of the testing device, including a color mosaic having at least one color value corresponding to a positive test result, comparing the color values of the test line image to the color values of the image of the color mosaic, determining if the color values of the image of the test line are within a predetermined range of the at least one color value of the image of the color mosaic corresponding to a positive test result; and presenting test results on the viewing screen.

Abstract: A method for generating medical trends based on medical test results by a server, comprising obtaining results from a first test related to a medical condition of a first patient, obtaining results from a second test related to a medical condition second patient, wherein the results include patient information and efficacy and dosage level information of a medication, comparing the patient information and the test results of the first patient with the patient information and the test results of the second patient, determining that a patient characteristic of the first patient matches a patient characteristic of the second patient, storing a potential trend, receiving a plurality of additional test results, determining that the potential trend is found in the additional test results in an amount that is above a threshold, and altering the potential trend to an active trend.

Abstract: A system and method are provided for collection and testing of a biologic sample. The system and method comprise collecting by a user of a testing device a biologic sample for use with the testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects further include presenting advertisements and other messages to users through a mobile application operating on a mobile device. These aspects take into account the results of the self-diagnostic test and present different advertisements to the user based on the results of the test.

Abstract: A method for correlating a retail testing product to medical codes is provided. The method comprises receiving a diagnostic test identifier at a server disposed on a network, retrieving a first medical code from a database, wherein the first medical code is associated with the diagnostic test identifier and the retail testing product, processing an image of the retail testing product to determine results of the test, retrieving a second medical code from the database, wherein the second medical code is associated with the test results, determining a recommended pharmaceutical product useful in treatment of at least one medical condition associated with the retail testing product, retrieving a third medical code from the database, where the third medical code is associated with the recommended pharmaceutical product, and transmitting the first medical code, the second medical code, and the third medical code to a healthcare entity.

Abstract: A method for initiating a telemedicine conference on a mobile device is provided. The method comprises receiving diagnostic test results in response to a diagnostic test, determining if the diagnostic test results include a positive result, storing the diagnostic test results on a server disposed on a network, presenting, if the diagnostic test results are positive, a telemedicine initiation option on a screen of the mobile device, determining whether the telemedicine initiation option is selected, sending the diagnostic test results from the server to the telemedicine provider, sending additional medical history information to the telemedicine provider, and initiating a telemedicine conference with the telemedicine provider.

Abstract: A method for administering tests using a regional antigen testing kit is provided. The method comprises providing the regional antigen testing kit, extracting a predetermined amount of concentrated antigen from one of a plurality of concentrated antigens, dispensing the predetermined amount of concentrated antigen into a corresponding one of a plurality of wells, as indicated by visual indicia, repeating the extracting and dispensing steps until a desired number of the plurality of wells contain concentrated antigen, providing a prick tester having a plurality of needles extending thereon, aligning the plurality of needles of the prick tester with the plurality of wells, inserting each of the plurality of needles of the prick tester into one of the plurality of wells, and applying the plurality of needles of the prick tester to the skin of a patient to elicit a potential response.

Abstract: A system for testing a treatment agent for a biologic material includes an input for receiving a biologic sample. A plurality of micro-pumps pump a portion of the biologic sample from the first reservoir into a connected module. A first module includes a first plurality of testing pathways for testing a first portion of the biologic sample. A first module connector removeably connects the first module to the distributor module. A second module includes a second plurality of testing pathways for testing a second portion of the biologic sample. The selected pathway applies at least one dosage level of a treatment agent to the second portion of the biologic sample. A second module connector removeably connects the second module to the distributor module, wherein treatment agent and the plurality of dosage levels tested by the system may be selected by selecting the second module associated with the second module connector.

Abstract: A system for chemosensory disorder testing includes a scanner for scanning a unique identifier associated with a test subject. A scent dispensing unit dispenses a predetermined scent for the test subject responsive to receipt of a dispensing control signal. A user interface receives a test response input from the test subject based on a perception of the test subject of the predetermined scent dispensed by the scent dispensing unit. A central controller generates the dispensing control signal responsive to the unique identifier scanned by the scanner. The central controller further determines at least one of a pass test result or a fail test result responsive to a comparison of the test response input to a predetermined response associated with the predetermined scent. A relational database stores the pass test result or the fail test result at a location associated with the unique identifier associated with the test subject.

Abstract: A system for providing colorimetric and ratiometric comparison and quantification for medical test results, comprising a testing device including an alignment target and including a plurality of immunoassay test strips, the plurality of immunoassay test strips each including a test line and a control line, and a colorimetry device configured to operate with a mobile device, the mobile device including a camera and a software application stored thereon, wherein the software application provides executable instructions to detect color properties of a color of the test line and a color of a control line of at least one of the plurality of immunoassay test strips, determine a risk value for each of at least one disease risks tested using the biologic sample, wherein the risk value is a rating determined from the color properties of the color of the test line, and provide medical test results based on the risk value.

Abstract: A two-sided flow-through immunoassay testing device is provided. The device comprises a well having therein a plurality of orifices, the plurality of orifices serving to channel biologic material deposited into the well onto different immunoassay pods, wherein the immunoassay pods may contain immunoassay test layers stacked to create an immunoassay test. The device further includes a results window. Inside the device, and between the window and the pods, there are open sections below each pod to allow a user to view the results of the tests as presented on the reaction layers of the pods through the window.

Abstract: A microfluidic chip system includes an input for receiving the biologic sample, and a first reading window for enabling a detection of the biologic material within the biologic sample. A first plurality of pathways is provided each for determining a treatment agent providing a best treatment efficacy for the predetermined biologic material. A first micro-pump is provided for pumping a portion of the biologic sample into each of the first plurality of pathways. A second plurality of pathways is provided, each for determining a dosage level of a particular one of the plurality of treatment agents with respect to the predetermined biologic material. A plurality of second micro-pumps are provided for pumping a second portion of the biologic sample into a selected one of the second plurality of pathways responsive to the determination of treatment efficacy of the treatment agent providing a best treatment of the predetermined biologic material.